Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Recurrent ERBB2 alterations are associated with esophageal adenocarcinoma brain metastases.

Lawson NM., Ye L., Cho CY., Zhao B., Mitchell T., Martín-Barrio I., Beernaert B., Gupta A., Banu M., Lissanu Y., Shaffer S., Tawbi H., Li J., Gule-Monroe MK., Alvarez-Breckenridge CA., Huse JT., Murphy MB., Yin F., Lang FF., Parkes EE., Weinberg JS., Akdemir KC.

DOI

10.1101/2025.02.19.25322558

Type

Preprint

Publication Date

26/02/2025

Keywords

ADC therapies, ERBB2, Esophageal adenocarcinoma, JAK2, T cell infiltration, brain metastasis, ecDNA, immunotherapy, micronuclei, tumor microenvironment

Permalink More information Close